Rev Esp Quimioter 2023; 36(5): 516-518

Role of Hologic® Panther AptimaTM SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?

CRISTINA GARCÍA-SALGUERO, LUIS VALLEJO, MERCERDES MARTÍNEZ-RODRÍGUEZ, ALBERTO DELGADO-IRIBARREN, ESTHER CULEBRAS

Published: 2 June 2023

http://www.doi.org/10.37201/req/135.2022

During the multiple waves of COVID-19 suffered all over the world, having a rapid and sensitive diagnostic test has become a priority for microbiology laboratories. The AptimaTM SARS-CoV-2 transcription-mediated amplification (TMA) assay running on the Panther system (Hologic) was presented as a very good option to cover this need. To evaluate this system, 570 respiratory samples were included in the study and were processed both by the Panther (Hologic) system and by qRT-PCR (Thermo Fisher Science, Waltham, USA), current assay for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A high number of false positives (n=76) was obtained with Panther system (Hologic), but the number of false positives decreases as the relative light units (RLU) value increases. These results show that this technique can be a good option for sample screening but checking for positive results should be mandatory, especially those with low RLU values.

Rev Esp Quimioter 2023; 36(5): 516-518 [Full-text PDF]